Cargando…
Glycine administration attenuates progression of dystrophic pathology in prednisolone-treated dystrophin/utrophin null mice
Duchenne muscular dystrophy (DMD) is an X-linked genetic disease characterized by progressive muscle wasting and weakness and premature death. Glucocorticoids (e.g. prednisolone) remain the only drugs with a favorable impact on DMD patients, but not without side effects. We have demonstrated that gl...
Autores principales: | Ham, Daniel J., Gardner, Anastasia, Kennedy, Tahnee L., Trieu, Jennifer, Naim, Timur, Chee, Annabel, Alves, Francesca M., Caldow, Marissa K., Lynch, Gordon S., Koopman, René |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6736947/ https://www.ncbi.nlm.nih.gov/pubmed/31506484 http://dx.doi.org/10.1038/s41598-019-49140-x |
Ejemplares similares
-
Metabolic remodeling of dystrophic skeletal muscle reveals biological roles for dystrophin and utrophin in adaptation and plasticity
por: Hardee, Justin P., et al.
Publicado: (2020) -
Deletion of suppressor of cytokine signaling 3 (SOCS3) in muscle stem cells does not alter muscle regeneration in mice after injury
por: Swiderski, Kristy, et al.
Publicado: (2019) -
Utrophin influences mitochondrial pathology and oxidative stress in dystrophic muscle
por: Kennedy, Tahnee L., et al.
Publicado: (2017) -
Dysfunctional Muscle and Liver Glycogen Metabolism in mdx Dystrophic Mice
por: Stapleton, David I., et al.
Publicado: (2014) -
Glycine Protects Muscle Cells From Wasting in vitro via mTORC1 Signaling
por: Caldow, Marissa K., et al.
Publicado: (2019)